Anti-KRAS G12D mutant (D113)

Anti-KRAS G12D mutant [D113], Recombinant, IgG1 kappa, Human
SKU
ABAAb03877-10.0
Packaging Unit
100 μg
Manufacturer
Absolute Antibody

Availability: loading...
Price is loading...
CloneID: D113

Antigen Long Description: The original antibody was generated by immunizing mice with a synthetic dodecapeptide 'KLVVVGADGVGK'.

Buffer Composition: PBS with 0.02% Proclin 300.

Available Custom Conjugation Options: AP, HRP, Fluorescein, APC, PE, Biotin Type A, Biotin Type B, Streptavidin, FluoroProbes 647H, Atto488, APC/Cy7, PE/Cy7

Uniprot Accession No.: P01116-2

Specificity Statement: This antibody binds the G12D mutant form of human KRAS protein. This ras protein binds GDP/GTP and possess intrinsic GTPase activity, that results in conversion of nucleotide guanosine triphosphate (GTP) into guanosine diphosphate (GDP). This protein plays an important role in many signal transduction pathways and regulation of cell proliferation. Somatic KRAS mutations are highly observed in leukemias, colorectal cancer, pancreatic cancer and lung cancer. KRAS mutation is G12D which is estimated to be present in up to 37% pancreatic cancers and over 12% of colorectal cancers.

Application Notes (Clone): The binding reactivity and epitope characterization of this antibody towards human KRAS G12D mutant was determined using ELISA (PMID: 9440050). This antibody can bind both the peptide 'KLVVVGADGVGK' conjugated BSA as well as KRAS G12D mutant in an ELISA.
More Information
SKU ABAAb03877-10.0
Manufacturer Absolute Antibody
Manufacturer SKU Ab03877-10.0
Package Unit 100 μg
Quantity Unit STK
Reactivity Human
Clonality Recombinant
Application ELISA
Isotype IgG1 kappa
Host Human
Product information (PDF) Download
MSDS (PDF) Download